Cohu Reports Fourth Quarter 2022 Results
Cohu, Inc. reported its fourth quarter 2022 net sales of $191.1 million with a GAAP income of $21.6 million or $0.45 per share. For the full year, net sales reached $812.8 million and GAAP income was $96.8 million, translating to $1.98 per share. The company reported a gross margin of 48.7% and a non-GAAP gross margin of 48.8%. Highlights include an annual subscription sign for the DI-Core software, a collaboration for advanced probe card solutions, and the acquisition of MCT Worldwide. Cohu anticipates first quarter 2023 sales between $173 million and $187 million.
- Gross margin increased by 470 basis points year-over-year.
- Successful acquisition of MCT Worldwide to enhance product portfolio.
- Introduction of a subscription-based predictive maintenance software.
- Full year net sales declined from $887.2 million in 2021 to $812.8 million in 2022.
- GAAP net income decreased from $167.3 million in 2021 to $96.8 million in 2022.
- Fourth quarter net sales decreased from $206.7 million in Q3 2022.
-
Gross margin of
48.7% ; non-GAAP gross margin of48.8% - Customer signs annual subscription for DI-Core predictive maintenance software
- Launched collaboration with Taiwanese partner to deliver advanced probe card solutions
-
Acquired
MCT Worldwide , expanding product portfolio and solutions for advanced packages in panel test
The Company also reported non-GAAP results, with fourth quarter 2022 income of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP Results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(in millions, except per share amounts) |
Q4 FY
|
|
Q3 FY
|
|
Q4 FY
|
|
12
|
|
12
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
Net sales |
|
$ |
191.1 |
|
$ |
206.7 |
|
$ |
191.9 |
|
$ |
812.8 |
|
$ |
887.2 |
|
|
|
Net income |
|
$ |
21.6 |
|
$ |
24.9 |
|
$ |
20.9 |
|
$ |
96.8 |
|
$ |
167.3 |
|
|
|
Net income per share |
|
$ |
0.45 |
|
$ |
0.51 |
|
$ |
0.42 |
|
$ |
1.98 |
|
$ |
3.45 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP Results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(in millions, except per share amounts) |
Q4 FY
|
|
Q3 FY
|
|
Q4 FY
|
|
12
|
|
12
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
Net income |
|
$ |
33.5 |
|
$ |
36.1 |
|
$ |
35.6 |
|
$ |
141.9 |
|
$ |
155.1 |
|
|
|
Net income per share |
|
$ |
0.70 |
|
$ |
0.74 |
|
$ |
0.72 |
|
$ |
2.91 |
|
$ |
3.20 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total cash and investments at the end of fourth quarter 2022 were
“We delivered another strong quarter of profit and cash flow. Gross margin was up 470 bps year-over-year and better than our target financial model as we made good progress managing costs, growing our recurring business, and selling differentiated products,” said
Conference Call Information:
The Company will host a live conference call and webcast with slides to discuss fourth quarter 2022 results at
About
Use of Non-GAAP Financial Information:
Included within this press release and accompanying materials are non-GAAP financial measures, including non-GAAP Gross Margin/Profit, Income and Income (adjusted earnings) per share, Operating Income, Operating Expense, effective tax rate, free cash flow and Adjusted EBITDA that supplement the Company’s Condensed Consolidated Statements of Operations prepared under generally accepted accounting principles (GAAP). These non-GAAP financial measures adjust the Company’s actual results prepared under GAAP to exclude charges and the related income tax effect for: share-based compensation, the amortization of purchased intangible assets, manufacturing transition and severance costs, acquisition-related costs and associated professional fees, restructuring costs, gain on sale of business, depreciation of purchase accounting adjustments to property, plant and equipment, employer payroll taxes related to accelerated vesting share-based awards, asset impairment charges, amortization of cloud-based software implementation costs (Adjusted EBITDA only) and loss on extinguishment of debt (Adjusted EBITDA only). Reconciliations of GAAP to non-GAAP amounts for the periods presented herein are provided in schedules accompanying this release and should be considered together with the Condensed Consolidated Statements of Operations. With respect to any forward-looking non-GAAP figures, we are unable to provide without unreasonable efforts, at this time, a GAAP to non-GAAP reconciliation of any forward-looking figures due to their inherent uncertainty.
These non-GAAP measures are not meant as a substitute for GAAP, but are included solely for informational and comparative purposes. The Company’s management believes that this information can assist investors in evaluating the Company’s operational trends, financial performance, and cash generating capacity. Management uses non-GAAP measures for a variety of reasons, including to make operational decisions, to determine executive compensation in part, to forecast future operational results, and for comparison to our annual operating plan. However, the non-GAAP financial measures should not be regarded as a replacement for (or superior to) corresponding, similarly captioned, GAAP measures.
Forward Looking Statements:
Certain statements contained in this release and accompanying materials may be considered forward-looking statements within the meaning of the
Actual results and future business conditions could differ materially from those contained in any forward-looking statement as a result of various factors, including, without limitation: cyclical COVID-19 pandemic impacts; new product investments and product enhancements which may not be commercially successful; inability to effectively manage multiple manufacturing sites in
These and other risks and uncertainties are discussed more fully in Cohu’s filings with the
For press releases and other information of interest to investors, please visit Cohu’s website at www.cohu.com.
|
||||||||||||||||
CONSOLIDATED STATEMENTS OF INCOME |
|
|
||||||||||||||
(Unaudited) |
|
|
|
|
||||||||||||
(in thousands, except per share amounts) |
||||||||||||||||
|
|
|
|
|
||||||||||||
|
Three Months Ended (1) |
Twelve Months Ended (1) |
||||||||||||||
|
|
|
|
|
||||||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
|||||||||
|
|
|
|
|
||||||||||||
Net sales |
$ |
191,105 |
|
$ |
191,860 |
|
$ |
812,775 |
|
$ |
887,214 |
|
||||
Cost and expenses: |
|
|
|
|
||||||||||||
Cost of sales (excluding amortization) |
|
97,954 |
|
|
107,466 |
|
|
429,449 |
|
|
500,253 |
|
||||
Research and development |
|
22,951 |
|
|
22,596 |
|
|
92,589 |
|
|
91,963 |
|
||||
Selling, general and administrative |
|
34,849 |
|
|
31,123 |
|
|
131,390 |
|
|
126,958 |
|
||||
Amortization of purchased intangible assets |
|
8,103 |
|
|
8,246 |
|
|
33,185 |
|
|
35,414 |
|
||||
Restructuring charges |
|
5 |
|
|
(165 |
) |
|
605 |
|
|
1,823 |
|
||||
Gain on sale of PCB Test business (2) |
|
- |
|
|
4,939 |
|
|
- |
|
|
(70,815 |
) |
||||
Impairment charges |
|
- |
|
|
100 |
|
|
- |
|
|
100 |
|
||||
|
|
163,862 |
|
|
174,305 |
|
|
687,218 |
|
|
685,696 |
|
||||
Income from operations |
|
27,243 |
|
|
17,555 |
|
|
125,557 |
|
|
201,518 |
|
||||
Other (expense) income: |
|
|
|
|
||||||||||||
Interest expense |
|
(1,249 |
) |
|
(1,041 |
) |
|
(4,177 |
) |
|
(6,413 |
) |
||||
Interest income |
|
2,461 |
|
|
42 |
|
|
4,012 |
|
|
239 |
|
||||
Foreign transaction gain (loss) |
|
(2,344 |
) |
|
726 |
|
|
1,635 |
|
|
411 |
|
||||
Loss on extinguishment of debt (3) |
|
- |
|
|
- |
|
|
(312 |
) |
|
(3,411 |
) |
||||
Income from operations before taxes |
|
26,111 |
|
|
17,282 |
|
|
126,715 |
|
|
192,344 |
|
||||
Income tax provision (benefit) |
|
4,483 |
|
|
(3,607 |
) |
|
29,868 |
|
|
25,019 |
|
||||
Net income |
$ |
21,628 |
|
$ |
20,889 |
|
$ |
96,847 |
|
$ |
167,325 |
|
||||
|
|
|
|
|
||||||||||||
Income per share: |
|
|
|
|
||||||||||||
Basic: |
$ |
0.46 |
|
$ |
0.43 |
|
$ |
2.01 |
|
$ |
3.53 |
|
||||
Diluted: |
$ |
0.45 |
|
$ |
0.42 |
|
$ |
1.98 |
|
$ |
3.45 |
|
||||
|
|
|
|
|
||||||||||||
Weighted average shares used in computing income per share: |
|
|
|
|
||||||||||||
Basic |
|
47,477 |
|
|
48,657 |
|
|
48,178 |
|
|
47,409 |
|
||||
Diluted |
|
48,175 |
|
|
49,427 |
|
|
48,799 |
|
|
48,460 |
|
||||
(1) |
|
The three- and twelve-month periods ended |
|
(2) |
|
On |
|
(3) |
|
Repayments of outstanding Term Loan B resulted in a loss from the extinguishment of debt. Loss on extinguishment of debt is the net result after any cash gain is offset by the required reduction in our capitalized debt issuance costs and original issuance discounts. |
|
||||||
CONDENSED CONSOLIDATED BALANCE SHEETS |
||||||
(Unaudited) |
||||||
(in thousands) |
|
|
||||
|
|
|
||||
|
2022 |
2021 |
||||
Assets: |
|
|
||||
Current assets: |
|
|
||||
Cash and investments |
$ |
385,576 |
$ |
379,905 |
||
Accounts receivable |
|
176,148 |
|
192,873 |
||
Inventories |
|
170,141 |
|
161,053 |
||
Other current assets |
|
32,986 |
|
16,962 |
||
Total current assets |
|
764,851 |
|
750,793 |
||
Property, plant & equipment, net |
|
65,011 |
|
63,957 |
||
|
|
213,539 |
|
219,791 |
||
Intangible assets, net |
|
140,104 |
|
177,320 |
||
Operating lease right of use assets |
|
22,804 |
|
25,060 |
||
Other assets |
|
21,105 |
|
22,123 |
||
Total assets |
$ |
1,227,414 |
$ |
1,259,044 |
||
|
|
|
||||
Liabilities & Stockholders’ Equity: |
|
|
||||
Current liabilities: |
|
|
||||
Short-term borrowings |
$ |
1,907 |
$ |
3,059 |
||
Current installments of long-term debt |
|
4,404 |
|
11,338 |
||
Deferred profit |
|
8,022 |
|
13,208 |
||
Other current liabilities |
|
146,539 |
|
164,854 |
||
Total current liabilities |
|
160,872 |
|
192,459 |
||
Long-term debt |
|
72,664 |
|
103,393 |
||
Non-current operating lease liabilities |
|
19,209 |
|
22,040 |
||
Other noncurrent liabilities |
|
45,828 |
|
58,650 |
||
|
|
928,841 |
|
882,502 |
||
Total liabilities & stockholders’ equity |
$ |
1,227,414 |
$ |
1,259,044 |
|
||||||||||||
Supplemental Reconciliation of GAAP Results to Non-GAAP Financial Measures (Unaudited) |
||||||||||||
(in thousands, except per share amounts) |
||||||||||||
|
Three Months Ended |
|||||||||||
|
|
|
|
|||||||||
|
2022 |
2022 |
2021 |
|||||||||
Income from operations - GAAP basis (a) |
$ |
27,243 |
|
$ |
33,707 |
|
$ |
17,555 |
|
|||
Non-GAAP adjustments: |
|
|
|
|||||||||
Share-based compensation included in (b): |
|
|
|
|||||||||
Cost of sales (COS) |
|
168 |
|
|
161 |
|
|
136 |
|
|||
Research and development (R&D) |
|
767 |
|
|
755 |
|
|
584 |
|
|||
Selling, general and administrative (SG&A) |
|
2,888 |
|
|
2,824 |
|
|
2,329 |
|
|||
|
|
3,823 |
|
|
3,740 |
|
|
3,049 |
|
|||
Amortization of purchased intangible assets (c) |
|
8,103 |
|
|
8,206 |
|
|
8,246 |
|
|||
Restructuring charges related to inventory adjustments in COS (d) |
|
(35 |
) |
|
(58 |
) |
|
141 |
|
|||
Restructuring charges included in operating expenses (d): |
|
|
|
|||||||||
Selling, general and administrative |
|
- |
|
|
- |
|
|
10 |
|
|||
Restructuring charges (d) |
|
5 |
|
|
17 |
|
|
(165 |
) |
|||
Manufacturing and sales transition costs included in (e): |
|
|
|
|||||||||
COS |
|
(13 |
) |
|
- |
|
|
(7 |
) |
|||
R&D |
|
(7 |
) |
|
- |
|
|
- |
|
|||
SG&A |
|
1,723 |
|
|
- |
|
|
(2 |
) |
|||
|
|
1,703 |
|
|
- |
|
|
(9 |
) |
|||
Impairment charges (f) |
|
- |
|
|
- |
|
|
100 |
|
|||
Loss on sale of PCB Test business (g) |
|
- |
|
|
- |
|
|
4,939 |
|
|||
Acquisition costs included in SG&A (h) |
|
72 |
|
|
- |
|
|
- |
|
|||
Reduction of indemnification receivable included in SG&A (i) |
|
- |
|
|
- |
|
|
75 |
|
|||
Income from operations - non-GAAP basis (j) |
$ |
40,914 |
|
$ |
45,612 |
|
$ |
33,941 |
|
|||
|
|
|
|
|||||||||
Net income - GAAP basis |
$ |
21,628 |
|
$ |
24,882 |
|
$ |
20,889 |
|
|||
Non-GAAP adjustments (as scheduled above) |
|
13,671 |
|
|
11,905 |
|
|
16,386 |
|
|||
Tax effect of non-GAAP adjustments (k) |
|
(1,761 |
) |
|
(685 |
) |
|
(1,650 |
) |
|||
Net income - non-GAAP basis |
$ |
33,538 |
|
$ |
36,102 |
|
$ |
35,625 |
|
|||
|
|
|
|
|||||||||
GAAP net income per share - diluted |
$ |
0.45 |
|
$ |
0.51 |
|
$ |
0.42 |
|
|||
|
|
|
|
|||||||||
Non-GAAP net income per share - diluted (l) |
$ |
0.70 |
|
$ |
0.74 |
|
$ |
0.72 |
|
|||
|
|
|
|
Management believes the presentation of these non-GAAP financial measures, when taken together with the corresponding GAAP financial measures, provides meaningful supplemental information regarding the Company’s operating performance. Our management uses these non-GAAP financial measures in assessing the Company's operating results, as well as when planning, forecasting and analyzing future periods and these non-GAAP measures allow investors to evaluate the Company’s financial performance using some of the same measures as management. Management views share-based compensation as an expense that is unrelated to the Company’s operational performance as it does not require cash payments and can vary in amount from period to period and the elimination of amortization charges provides better comparability of pre- and post-acquisition operating results and to results of businesses utilizing internally developed intangible assets. Management initiated certain restructuring activities including employee headcount reductions and other organizational changes to align our business strategies in light of the merger with
(a) |
|
|
||
(b) |
|
To eliminate compensation expense for employee stock options, stock units and our employee stock purchase plan. |
||
(c) |
|
To eliminate the amortization of acquired intangible assets. |
||
(d) |
|
To eliminate restructuring costs incurred related to the integration of |
||
(e) |
|
To eliminate the manufacturing transition and severance costs. |
||
(f) |
|
To eliminate impairment charges recorded to adjust IPR&D assets to fair value. |
||
(g) |
|
To eliminate the loss generated from the sale of the PCB Test business. |
||
(h) |
|
To eliminate professional fees and other direct incremental expenses incurred related to acquisitions. |
||
(i) |
|
To eliminate the impact of the reduction of an uncertain tax position liability and related indemnification receivable. |
||
(j) |
|
|
||
(k) |
|
To adjust the provision for income taxes related to the adjustments described above based on applicable tax rates. |
||
(l) |
|
All periods presented were computed using the number of GAAP diluted shares outstanding. |
|
||||||||
Supplemental Reconciliation of GAAP Results to Non-GAAP Financial Measures (Unaudited) |
||||||||
(in thousands, except per share amounts) |
||||||||
|
Twelve Months Ended |
|||||||
|
|
|
||||||
|
2022 |
2021 |
||||||
Income from operations - GAAP basis (a) |
$ |
125,557 |
|
$ |
201,518 |
|
||
Non-GAAP adjustments: |
|
|
||||||
Share-based compensation included in (b): |
|
|
||||||
Cost of sales (COS) |
|
646 |
|
|
828 |
|
||
Research and development (R&D) |
|
3,100 |
|
|
3,017 |
|
||
Selling, general and administrative (SG&A) |
|
11,172 |
|
|
9,947 |
|
||
|
|
14,918 |
|
|
13,792 |
|
||
Amortization of purchased intangible assets (c) |
|
33,185 |
|
|
35,414 |
|
||
Restructuring charges related to inventory adjustments in COS (d) |
|
(454 |
) |
|
(558 |
) |
||
Restructuring charges included in operating expenses (d): |
|
|
||||||
Selling, general and administrative |
|
- |
|
|
10 |
|
||
Restructuring charges (d) |
|
605 |
|
|
1,823 |
|
||
Manufacturing and sales transition costs included in (e): |
|
|
||||||
COS |
|
(13 |
) |
|
(7 |
) |
||
R&D |
|
(7 |
) |
|
- |
|
||
SG&A |
|
1,723 |
|
|
(2 |
) |
||
|
|
1,703 |
|
|
(9 |
) |
||
Impairment charges (f) |
|
- |
|
|
100 |
|
||
|
|
|
||||||
Gain on sale of PCB Test business (g) |
|
- |
|
|
(70,815 |
) |
||
PP&E step-up included in SG&A (h) |
|
- |
|
|
435 |
|
||
Acquisition costs included in SG&A (i) |
|
72 |
|
|
- |
|
||
Reduction of indemnification receivable included in SG&A (j) |
|
- |
|
|
75 |
|
||
Payroll taxes related to accelerated vesting of share-based awards included in SG&A (k) |
|
132 |
|
|
300 |
|
||
|
|
|
||||||
Income from operations - non-GAAP basis (l) |
$ |
175,718 |
|
$ |
182,085 |
|
||
|
|
|
||||||
Net income - GAAP basis |
$ |
96,847 |
|
$ |
167,325 |
|
||
Non-GAAP adjustments (as scheduled above) |
|
50,161 |
|
|
(19,433 |
) |
||
Tax effect of non-GAAP adjustments (m) |
|
(5,063 |
) |
|
7,194 |
|
||
Net income - non-GAAP basis |
$ |
141,945 |
|
$ |
155,086 |
|
||
|
|
|
||||||
GAAP net income per share - diluted |
$ |
1.98 |
|
$ |
3.45 |
|
||
|
|
|
||||||
Non-GAAP income per share - diluted (n) |
$ |
2.91 |
|
$ |
3.20 |
|
||
|
|
|
Management believes the presentation of these non-GAAP financial measures, when taken together with the corresponding GAAP financial measures, provides meaningful supplemental information regarding the Company’s operating performance. Our management uses these non-GAAP financial measures in assessing the Company's operating results, as well as when planning, forecasting and analyzing future periods and these non-GAAP measures allow investors to evaluate the Company’s financial performance using some of the same measures as management. Management views share-based compensation as an expense that is unrelated to the Company’s operational performance as it does not require cash payments and can vary in amount from period to period and the elimination of amortization charges provides better comparability of pre- and post-acquisition operating results and to results of businesses utilizing internally developed intangible assets. Management initiated certain restructuring activities including employee headcount reductions and other organizational changes to align our business strategies in light of the merger with
(a) |
|
|
|
(b) |
|
To eliminate compensation expense for employee stock options, stock units and our employee stock purchase plan. |
|
(c) |
|
To eliminate the amortization of acquired intangible assets. |
|
(d) |
|
To eliminate restructuring costs incurred related to the integration of |
|
(e) |
|
To eliminate the manufacturing transition and severance costs. |
|
(f) |
|
To eliminate impairment charges recorded to adjust IPR&D assets to fair value. |
|
(g) |
|
To eliminate the gains generated from the sale of the PCB Test business. |
|
(h) |
|
To eliminate the property, plant & equipment step-up depreciation accelerated related to the acquisition of |
|
(i) |
|
To eliminate professional fees and other direct incremental expenses incurred related to acquisitions. |
|
(j) |
|
To eliminate the impact of the reduction of an uncertain tax position liability and related indemnification receivable. |
|
(k) |
|
To eliminate the impact of employer payroll taxes associated with the acceleration of |
|
(l) |
|
|
|
(m) |
|
To adjust the provision for income taxes related to the adjustments described above based on applicable tax rates. |
|
(n) |
|
All periods presented were computed using the number of GAAP diluted shares outstanding. |
|
||||||||||||
Supplemental Reconciliation of GAAP Results to Non-GAAP Financial Measures (Unaudited) |
||||||||||||
(in thousands) |
|
|
|
|||||||||
|
Three Months Ended |
|||||||||||
|
|
|
|
|||||||||
|
2022 |
2022 |
2021 |
|||||||||
|
|
|
|
|||||||||
Gross Profit Reconciliation |
|
|
|
|||||||||
Gross profit - GAAP basis (excluding amortization) (1) |
$ |
93,151 |
|
$ |
98,066 |
|
$ |
84,394 |
|
|||
Non-GAAP adjustments to cost of sales (as scheduled above) |
|
120 |
|
|
103 |
|
|
270 |
|
|||
Gross profit - Non-GAAP basis |
$ |
93,271 |
|
$ |
98,169 |
|
$ |
84,664 |
|
|||
|
|
|
|
|||||||||
As a percentage of net sales: |
|
|
|
|||||||||
GAAP gross profit |
|
48.7 |
% |
|
47.4 |
% |
|
44.0 |
% |
|||
Non-GAAP gross profit |
|
48.8 |
% |
|
47.5 |
% |
|
44.1 |
% |
|||
|
|
|
|
|||||||||
Adjusted EBITDA Reconciliation |
|
|
|
|||||||||
Net income - GAAP Basis |
$ |
21,628 |
|
$ |
24,882 |
|
$ |
20,889 |
|
|||
Income tax provision (benefit) |
|
4,483 |
|
|
10,193 |
|
|
(3,607 |
) |
|||
Interest expense |
|
1,249 |
|
|
1,028 |
|
|
1,041 |
|
|||
Interest income |
|
(2,461 |
) |
|
(1,132 |
) |
|
(42 |
) |
|||
Amortization of purchased intangible assets |
|
8,103 |
|
|
8,206 |
|
|
8,246 |
|
|||
Depreciation |
|
3,268 |
|
|
3,240 |
|
|
3,219 |
|
|||
Amortization of cloud-based software implementation costs (2) |
|
626 |
|
|
478 |
|
|
487 |
|
|||
Loss on extinguishment of debt |
|
- |
|
|
80 |
|
|
- |
|
|||
Other non-GAAP adjustments (as scheduled above) |
|
5,568 |
|
|
3,699 |
|
|
8,140 |
|
|||
Adjusted EBITDA |
$ |
42,464 |
|
$ |
50,674 |
|
$ |
38,373 |
|
|||
|
|
|
|
|||||||||
As a percentage of net sales: |
|
|
|
|||||||||
Net income - GAAP Basis |
|
11.3 |
% |
|
12.0 |
% |
|
10.9 |
% |
|||
Adjusted EBITDA |
|
22.2 |
% |
|
24.5 |
% |
|
20.0 |
% |
|||
|
|
|
|
|||||||||
Operating Expense Reconciliation |
|
|
|
|||||||||
Operating Expense - GAAP basis |
$ |
65,908 |
|
$ |
64,359 |
|
$ |
61,900 |
|
|||
Non-GAAP adjustments to operating expenses (as scheduled above) |
|
(13,551 |
) |
|
(11,802 |
) |
|
(11,177 |
) |
|||
Operating Expenses - Non-GAAP basis |
$ |
52,357 |
|
$ |
52,557 |
|
$ |
50,723 |
|
|||
(1) |
|
Excludes amortization of |
(2) |
|
Represents amortization of capitalized implementation costs related to cloud-based software arrangements that are included within SG&A. |
|
Twelve Months Ended |
|||||||
|
|
|
||||||
|
2022 |
2021 |
||||||
Gross Profit Reconciliation |
|
|
||||||
Gross profit - GAAP basis (excluding amortization) (1) |
$ |
383,326 |
|
$ |
386,961 |
|
||
Non-GAAP adjustments to cost of sales (as scheduled above) |
|
179 |
|
|
263 |
|
||
Gross profit - Non-GAAP basis |
$ |
383,505 |
|
$ |
387,224 |
|
||
|
|
|
||||||
As a percentage of net sales: |
|
|
||||||
GAAP gross profit |
|
47.2 |
% |
|
43.6 |
% |
||
Non-GAAP gross profit |
|
47.2 |
% |
|
43.6 |
% |
||
|
|
|
||||||
Adjusted EBITDA Reconciliation |
|
|
||||||
Net income - GAAP Basis |
$ |
96,847 |
|
$ |
167,325 |
|
||
Income tax provision |
|
29,868 |
|
|
25,019 |
|
||
Interest expense |
|
4,177 |
|
|
6,413 |
|
||
Interest income |
|
(4,012 |
) |
|
(239 |
) |
||
Amortization of purchased intangible assets |
|
33,185 |
|
|
35,414 |
|
||
Depreciation |
|
12,831 |
|
|
13,153 |
|
||
Amortization of cloud-based software implementation costs (2) |
|
2,060 |
|
|
1,644 |
|
||
Loss on extinguishment of debt |
|
312 |
|
|
3,411 |
|
||
Other non-GAAP adjustments (as scheduled above) |
|
16,976 |
|
|
(55,282 |
) |
||
Adjusted EBITDA |
$ |
192,244 |
|
$ |
196,858 |
|
||
|
|
|
||||||
As a percentage of net sales: |
|
|
||||||
Net income - GAAP Basis |
|
11.9 |
% |
|
18.9 |
% |
||
Adjusted EBITDA |
|
23.7 |
% |
|
22.2 |
% |
||
|
|
|
||||||
Operating Expense Reconciliation |
|
|
||||||
Operating Expense - GAAP basis |
$ |
257,769 |
|
$ |
256,258 |
|
||
Non-GAAP adjustments to operating expenses (as scheduled above) |
|
(49,982 |
) |
|
(51,119 |
) |
||
Operating Expenses - Non-GAAP basis |
$ |
207,787 |
|
$ |
205,139 |
|
||
(1) |
|
Excludes amortization of |
(2) |
|
Represents amortization of capitalized implementation costs related to cloud-based software arrangements that are included within SG&A. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20230216005205/en/
858-848-8106
Source:
FAQ
What were Cohu's fourth quarter 2022 net sales and income?
How did Cohu's gross margin perform in Q4 2022?
What guidance did Cohu provide for Q1 2023?